Oral docetaxel plus encequidar – A pharmacokinetic model and evaluation against IV docetaxel
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Oral docetaxel plus encequidar – A pharmacokinetic model and evaluation against IV docetaxel ; volume:51 ; number:4 ; day:19 ; month:3 ; year:2024 ; pages:335-352 ; date:8.2024
Journal of pharmacokinetics and pharmacodynamics ; 51, Heft 4 (19.3.2024), 335-352, 8.2024
- Urheber
-
Wang, David
Jackson, Chris
Hung, Noelyn
Hung, Tak
Kwan, Rudolf
Chan, Wing-Kai
Qin, Albert
Hughes-Medlicott, Natalie J.
Glue, Paul
Duffull, Stephen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10928-024-09913-y
- URN
-
urn:nbn:de:101:1-2410080926054.563586921111
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, David
- Jackson, Chris
- Hung, Noelyn
- Hung, Tak
- Kwan, Rudolf
- Chan, Wing-Kai
- Qin, Albert
- Hughes-Medlicott, Natalie J.
- Glue, Paul
- Duffull, Stephen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota
Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Severe Photo Toxicity Recalled by Docetaxel
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
Novel Docetaxel-Loaded Micelles Based on all-trans-Retinoic Acid: Preparation and Pharmacokinetic Study in Rats
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Kastrationsresistentes Prostatakarzinom unter Docetaxel : eine pharmakoökonomische Studie
Docetaxel enhances lysosomal function through TFEB activation
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota
Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Severe Photo Toxicity Recalled by Docetaxel
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
Novel Docetaxel-Loaded Micelles Based on all-trans-Retinoic Acid: Preparation and Pharmacokinetic Study in Rats
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Kastrationsresistentes Prostatakarzinom unter Docetaxel : eine pharmakoökonomische Studie
Docetaxel enhances lysosomal function through TFEB activation
Correction: Oral docetaxel plus encequidar – a pharmacokinetic model and evaluation against IV docetaxel
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer
Effects of Docetaxel Injection and Docetaxel Micelles on the Intestinal Barrier and Intestinal Microbiota
Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Severe Photo Toxicity Recalled by Docetaxel
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
Novel Docetaxel-Loaded Micelles Based on all-trans-Retinoic Acid: Preparation and Pharmacokinetic Study in Rats
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Kastrationsresistentes Prostatakarzinom unter Docetaxel : eine pharmakoökonomische Studie